Mark Awad
MD, PhD
Clinical Director of Thoracic Oncology
👥Biography 个人简介
Dr. Mark Awad is a leading thoracic oncologist specializing in molecularly targeted therapies for NSCLC. He has led the KRYSTAL-1 trial evaluating adagrasib in KRAS G12C-mutant lung cancer and contributed fundamental insights into co-mutation landscapes that modulate KRAS inhibitor response. His laboratory investigates acquired resistance mechanisms to KRAS G12C inhibitors including secondary KRAS mutations.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Mark Awad 的研究动态
Follow Mark Awad's research updates
留下邮箱，当我们发布与 Mark Awad（Brigham and Women's Hospital / Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment